key: cord-1025682-lvmxgfwy
authors: Javalkote, Vivek S.; Kancharla, Nagesh; Bhadra, Bhaskar; Shukla, Manish; Soni, Badrish; Goodin, Michael; Bandyopadhyay, Anindya; Dasgupta, Santanu
title: CRISPR-based assays for rapid detection of SARS-CoV-2
date: 2020-10-10
journal: Methods
DOI: 10.1016/j.ymeth.2020.10.003
sha: c7df47ff2c9ae8b8fef0b9d7db5232621d48f5ad
doc_id: 1025682
cord_uid: lvmxgfwy

COVID-19 pandemic posed an unprecedented threat to global public health and economies. There is no effective treatment of the disease, hence, scaling up testing for rapid diagnosis of SARS-CoV-2 infected patients and quarantine them from healthy individuals is one the best strategies to curb the pandemic. Establishing globally accepted easy-to-access diagnostic tests is extremely important to understanding the epidemiology of the present pandemic. While nucleic acid based tests are considered to be more sensitive with respect to serological tests but present gold standard qRT-PCR-based assays possess limitations such as low sample throughput, requirement for sophisticated reagents and instrumentation. To overcome these shortcomings, recent efforts of incorporating LAMP-based isothermal detection, and minimizing the number of reagents required are on rise. CRISPR based novel techniques, when merge with isothermal and allied technologies, promises to provide sensitive and rapid detection of SARS-CoV-2 nucleic acids. Here, we discuss and present compilation of state-of-the-art detection techniques for COVID-19 using CRISPR technology which has tremendous potential to transform diagnostics and epidemiology.

increasing number of cases throughout the world, that leads to pandemic declaration by WHO (World 33

Health Organization). Since the declaration of the COVID-19 pandemic on 11 th of March 2020 by the 34 WHO, more than 5.6 million people worldwide have been infected with SARS-CoV-2, resulting in more 35 than 356254 fatalities till 29 th May 2020 [5] . An accurate view of the epidemiology of this disease 36 requires rapid testing and identification to inform followed by contact tracing and quarantine 37 strategies necessary to slow the rate of transmission [6] . Complicating the epidemiology of COVID-19 38 is the finding that Pre-symptomatic carriers are capable to shed/transmit SARS-CoV-2 prior to onset 39 of symptoms [7] . 40

At present, two general types of tests are available for COVID-19, namely, serological tests and nucleic 41 acid-based tests. While serological detection has the advantages of being easier to conduct, without 42 need for sophisticated instruments, these tests depend on antibody detection, which requires 43 seroconversion to occur in patients prior to administration of the test. During the incubation period 44 of 5-14 days prior to symptom onset, serological tests may suffer from a high rate of false-negative 45 a) Nasopharyngeal swab collection from infected patients b) RNAs extracted from samples (red strand) c) 56 Reverse transcription for cDNA synthesis (green strand) and amplification (RT-PCR) conducted by using target 57 specific primers (eg. SARS-CoV-2 N gene or RDRP gene) d) Quantitative real time PCR (qRT-PCR) conducted to 58 identify positive samples. Amplification of sample monitored in real time based on fluorescence generated by 59 incorporation of dyes like SYBR green in double stranded DNA. Further TaqMan probes specific to target 60 sequence increases the specificity and sensitivity.

There are several drawbacks to qRT-PCR-based tests, such as the requirement for a centralized 62 laboratory, trained technical staff, sophisticated instrumentation, and expensive reagents that may 63 not be available at the point of care. Additionally, the overall turnaround time may be quite long. 64

Although detection assays themselves may only require 3-4 hours, collection, transport, and data 65 analyses may extend reporting to greater than 24 hours. 66

The other promising nucleic acid based test is RT-LAMP (Loop-mediated isothermal amplification) and 67 its refined version known as RT-RPA (Recombinase Polymerase amplification) [10, 11] . Both the 68 methods are alternatives to qRT-PCR method. Since these are isothermal amplification techniques, a 69 simple heating block can replace expensive thermocycler machines. Elimination of thermocycling 70 helps in reduction of overall time needed for the tests and reduces the cost per assay. 71

The LAMP technique involves targeting of 6 target sequences with 4 primers along with application of 72 a strand-displacing DNA polymerase [10]. Targeting of several sequences simultaneously makes the 73 assay highly selective for SARS-CoV-2. The reaction endpoint can be determined using double-74 stranded DNA binding dyes or colorimetric pH indicator dyes (Fig-2) 3) Neutralization assay (detection in 3 to 5 days).

[ 

Use of dual TaqMan probes 373 to increase the sensitivity of 1-step quantitative reverse transcription-PCR: application to the 374 detection of SARS coronavirus

Preparation of armored RNA as a 377 control for multiplex real-time reverse transcription-PCR detection of influenza virus and 378 severe acute respiratory syndrome coronavirus

Development and Validation of Reverse Transcription Loop-Mediated Isothermal

Amplification (RT-LAMP) for Rapid Detection of ZIKV in Mosquito Samples from Brazil

Initial performance 385 evaluation of a spotted array Mobile Analysis Platform (MAP) for the detection of influenza

Next-generation diagnostics with CRISPR

A protocol for detection 404 of COVID-19 using CRISPR diagnostics

All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for

Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus

Enhancement of trans-cleavage activity of Cas12a with 409 engineered crRNA enables amplified nucleic acid detection

Nucleic 412 acid detection with CRISPR-Cas13a/C2c2

Field-deployable viral diagnostics using CRISPR-Cas13

CRISPR-Cas guides the future of genetic engineering

CRISPR-Assisted DNA Detection, a novel 420 dCas9-based DNA detection technique

Title of the review: CRISPR-based assays for rapid detection of SARS-CoV

Highlights : Covid-19 detection technique, CRISPR based assays

Authors mentioned that there is no conflict of interest involved in the study and development of the 447 review